STAT+: Pharmalittle: Gilead faces partial clinical hold on blood cancer drug; Rhode Island agrees to opioid deal with wholesalers
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
Author: STAT
STAT+: Akili, maker of prescription video game to treat ADHD, to go public via SPAC
SPACs aren’t all fun and games, until they are. Akili Interactive, which makes a video…
STAT+: Studies of Gilead blood cancer drug interrupted by emerging safety issue, clouding its future
The development of a blood cancer drug acquired by Gilead Sciences — the centerpiece of…
Opinion: Listen: Burnout at the bedside is causing a crisis in nursing
Two years into the pandemic and in the midst of the latest hospital staffing crisis,…
Opinion: How Black hair racism affects mental health care
As a Black woman with long, poofy hair, I was delighted to see Oregon join…
Why Hong Kong may become a living laboratory in search for Covid-19 answers
In the two months since it first hit the world’s Covid-19 radar, scientists have generated…
STAT+: A former FDA official on making the jump to health tech startups
Since stepping down from his post at the Food and Drug Administration last year, Anand…
STAT+: Insufficient progress is being made in reporting clinical trial results in the U.S.
As scrutiny into clinical trial disclosure intensifies, a new analysis finds 13 U.S. companies and…
Key senators propose an overhaul of how the U.S. prepares for pandemics
WASHINGTON — A powerful, bipartisan duo of senators wants to empower Congress to ensure the…
Telehealth lobbying is soaring to new heights
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: What risks? FDA scolds Lilly for misleading Instagram post about a best-selling diabetes drug
Eli Lilly (LLY) was rebuked by the U.S. Food and Drug Administration for running a…
STAT+: Pharmalittle: Pfizer and BioNTech start trial of Omicron-targeted vaccine; insulin makers boost lobbying spending
Top of the morning to you, and a fine one it is. Although gray skies…
STAT+: Pivotal study shows Sierra Oncology drug improves anemia and other symptoms of myelofibrosis
Sierra Oncology said Tuesday that its experimental treatment for the blood cancer myelofibrosis achieved all…
As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear
Pfizer and BioNTech have started a study comparing their Omicron-based Covid-19 vaccine to the original vaccine,…
Opinion: Learning from Covid-19 requires a modeling renaissance
“Flatten the curve” was a rallying cry in early 2020 as Covid-19 began sweeping across…
Opinion: STAT+: What’s blocking health care boards’ progress in diversity, equity, and inclusion?
Governing boards of health systems tend to be conservative and bound by tradition, often populated…
STAT+: Can open datasets help machine learning solve medical mysteries?
The medical data housed in patient records are a clinical researcher’s dream: the key, potentially,…
It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers
The scientists stressed the caveats that early-stage research demands: the compounds they had studied showed…
STAT+: Insulin giants Eli Lilly and Novo Nordisk boosted their lobbying spending as Democrats eyed pricing reform
WASHINGTON — As lawmakers took aim at high insulin costs, two major insulin manufacturers increased…
STAT+: Fearing spies, Sanofi wants to nix new condo towers that will overlook a Toronto vaccine plant
In an unusual move, Sanofi (SNY) is urging the Toronto City Council to restrict development…
STAT+: Pfizer faces calls to quickly sell more Covid-19 pills to poorer countries
Amid concerns over access to Covid-19 vaccines and treatments, Pfizer (PFE) is being urged by…
STAT+: Pharmalittle: Did Hal Barron hit his goals before leaving Glaxo? FDA rejects drugs from Merck and Pfizer
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Biotech stocks are a dumpster fire. An analyst explains what’s going on
In the midst of a pandemic that proved that the biotech industry has the power…
Opinion: Antigen testing has some serious problems. Done right, it could reshape the future of health care
The Omicron variant of SARS-CoV-2 has renewed attention on Covid-19 antigen test kits. They are…
Opinion: We all need help working through grief and hardship
What do you say at work when you’re not really OK? More to the point,…
STAT+: Did veteran drug developer Hal Barron accomplish his mission at GSK?
So here’s the big question for Hal Barron as he departs GlaxoSmithKline: Did he accomplish…
STAT+: ‘We must change’: Health systems invest more aggressively than ever in digital health
During his talk at the recent J.P. Morgan Healthcare Conference, Mayo Clinic CEO Gianrico Farrugia…
Building on a study of Covid drugs, scientists launch effort to accelerate clinical trials for other diseases
A group of scientists who did more than perhaps any other to test new treatments…
Opinion: Using force crossed my mind when examining a defiant young patient. A short story made me take a breath
As I struggled to examine Johnny, an 8-year-old boy who refused to let me see…
STAT+: The sale of Watson Health assets ends a dark chapter for IBM. For its buyer, the opportunity looks brighter
With the sale of core parts of its Watson Health business, IBM is seeing its…
Listen: Biotech’s red tape, the latest billionaire science project, & a (possible) Omicron reprieve
Why does everyone hate biotech stocks? Can Big Science create an actual business? And what…
STAT+: New research casts doubt on how combination cancer therapies work in tandem
Some drugs are thought to be more powerful together: aspirin and coffee, cannabis and alcohol,…
Kisses, licks, and drool: Study shows how ‘saliva sharing’ shapes babies’ understanding of the closest relationships
Raising a young child can be a bit … messy. There’s the drool to be…
Opinion: To get to a ‘new normal,’ public health must focus on all respiratory viruses
Much of the response to Covid-19 to date has been reactionary. Travel restrictions were implemented…
STAT+: Pharmalittle: 27 companies will make generic Merck Covid pills; drug-resistant infections are deadlier than HIV or malaria
Good morning, everyone, and how are you today? A spot of snow is dusting the…
After a flurry of firsts, xenotransplantation is suddenly back in the spotlight
In his more than 30 years as a surgeon, Robert Montgomery has transplanted hundreds of…
Opinion: This HIV prevention medicine is for everyone. Why do so few people take it?
About 60% of older Americans take a cholesterol-lowering statin to prevent heart attack, stroke, and…
Opinion: Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
One Thursday in September, I woke up with achy knees. That was nothing new. I’ve…
Watch: In medicine, fax machines are still vital technology
In a world where everything from your TV to wristwatch has an internet connection, the…
‘The scientists, they’re learning more’: A defiant Biden defends the CDC amid mounting criticism
WASHINGTON — President Biden on Wednesday defended the Centers for Disease Control and Prevention, amid…
Opinion: New global data showing 1.27 million deaths a year reveal the urgent need to address antimicrobial resistance
Antimicrobial resistance is a critical global health threat, affecting the human, animal, and environmental health…
Negative descriptors are more likely to appear in health records of Black patients, study finds
Doctors’ notes are meant to be an objective record of their interactions with patients. Among…
STAT+: Analysis of JAMA and NEJM articles finds most authors failed to disclose conflicts
Amid ongoing concerns over conflicts of interest that may affect medical practice, a new analysis…
New data show those who recovered from Covid-19 were less likely than vaccinated to get infected during Delta wave
New data released Wednesday showed that both vaccination and prior infection offered strong protection against…
Can mailing free Covid-19 tests turn Biden’s pandemic response around?
WASHINGTON — In an effort to regain the trust of the American public when it…
Opinion: Covid-19 is no longer the biggest issue facing hospitals. Staffing is
Health care providers have been the frontline of our nation’s battle against the Covid-19 pandemic,…
STAT+: Pharmalittle: Disease ‘reversal’ startup launches with $3 billion and biotech vets; network distributed fake Gilead HIV meds
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Senate Finance chair investigates Bristol Myers over an allegedly abusive overseas tax shelter
The head of the U.S. Senate Committee is seeking details from Bristol Myers Squibb (BMY)…
STAT+: A new RNA-based drug startup launches with Rutgers science and money connections
A Philadelphia-based biotech startup — by way of Rutgers University in New Jersey — has…
STAT+: Belgian pharma UCB to buy Zogenix, maker of rare epilepsy treatment, for $1.9 billion
Belgian drug maker UCB said Wednesday that it is expanding its portfolio of epilepsy treatments…